Why is a magnet required and when should the pacemaker be deactivated in a pregnant patient with long QT syndrome undergoing procedures with monopolar electrocautery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Magnet Use and Device Deactivation in Pregnant LQTS Patients Undergoing Monopolar Electrocautery

A magnet is needed to temporarily disable ICD shock therapy during procedures with monopolar electrocautery to prevent inappropriate shocks from electromagnetic interference, and the device should be deactivated when the surgical field is above the umbilicus or when monopolar electrocautery is used in proximity to the device. 1

Why a Magnet is Required

The magnet serves a critical protective function during surgical procedures:

  • Prevents inappropriate ICD shocks: Monopolar electrocautery generates electromagnetic interference that can be misinterpreted by the ICD as a ventricular arrhythmia, triggering inappropriate shock delivery 2, 3
  • Maintains pacing function: While the magnet disables tachyarrhythmia detection and shock therapy in ICDs, it does not affect the pacing function, which remains active 1
  • Provides immediate reversibility: Unlike device reprogramming, magnet application offers instant on/off control that can be removed immediately after the procedure 2

When Device Deactivation is Indicated

The decision to deactivate depends on surgical location and electrocautery type:

Mandatory Deactivation Scenarios:

  • Abdominal incisions above the umbilicus with monopolar electrocautery 1
  • Any procedure where the surgical field is in close proximity to the device
  • Supra-umbilical procedures in pacemaker-dependent patients (requires reprogramming, not just magnet) 2

Magnet vs. Reprogramming Decision Algorithm:

For ICD patients (non-pacemaker dependent):

  • Surgery above umbilicus with monopolar electrocautery → Preferably reprogram to "safe mode" via cardiac physiologist 1
  • Surgery below umbilicus with monopolar electrocautery → Magnet application acceptable 3
  • Surgery with bipolar electrocautery (any location) → Magnet application acceptable 3
  • Lower extremity surgery with bipolar electrocautery → May not require deactivation 3

For pacemaker patients:

  • Pacemakers typically do not require deactivation for electrocautery unless the patient is pacemaker-dependent and undergoing high-risk interference procedures 2

Critical Safety Requirements During Magnet Use

When using a magnet for ICD deactivation 1:

  1. Secure placement: Tape the medical-grade ring magnet over the ICD so it does not move
  2. Continuous monitoring: Maintain 3-lead ECG monitoring with alarms throughout the entire period of deactivation
  3. Immediate defibrillation availability: Keep an external defibrillator at bedside
  4. Timely removal: Remove the magnet immediately after surgery to restore tachyarrhythmia detection
  5. Post-procedure device check: Perform full device interrogation after the procedure

Common Pitfalls to Avoid

  • Never delay emergency procedures (like perimortem cesarean section) to place a magnet—maternal resuscitation takes priority 1
  • Do not use amiodarone or procainamide for torsades de pointes in LQTS patients, as these prolong the QT interval further 4
  • Avoid switching beta-blockers during pregnancy—continue nadolol or propranolol rather than switching to metoprolol 4, 5
  • Do not assume all devices respond identically to magnets—manufacturer-specific responses vary 6, 7

Special Considerations for Pregnant LQTS Patients

For the pregnant patient with LQTS specifically:

  • Continue beta-blocker therapy (nadolol or propranolol) throughout pregnancy, labor, and postpartum 4, 5
  • Highest risk period is postpartum (9 months after delivery), not during pregnancy 5
  • Vaginal delivery is safe with adequate analgesia and minimized labor duration to avoid adrenergic surges 4
  • ICD implantation is rarely needed in LQTS—most patients are managed with beta-blockers alone 4, 8

References

Guideline

cardiac implantable electronic devices in pregnancy: a position statement.

BJOG : an international journal of obstetrics and gynaecology, 2024

Research

Magnet Use for implantable cardiac devices: A Practical Guide.

Anaesthesia, critical care & pain medicine, 2025

Research

Clinical applications of magnets on cardiac rhythm management devices.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011

Research

Managing long QT syndrome patients, cooking, and common sense.

European heart journal supplements : journal of the European Society of Cardiology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.